Article Details
Retrieved on: 2024-12-10 00:08:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The CD38-directed monoclonal antibody isatuximab (Sarclisa) combined with initial bortezomib (Velcade), lenalidomide (Revlimid), and dexamethasone ...
Article found on: www.onclive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here